APA

Smolinska A., Bodelier A. G. L., Dallinga J. W., Masclee A. A. M., Jonkers D. M., van Schooten F. & Pierik M. J. (20170815). The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis. : Alimentary pharmacology & therapeutics.

Chicago

Smolinska A, Bodelier A G L, Dallinga J W, Masclee A A M, Jonkers D M, van Schooten F-J and Pierik M J. 20170815. The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis. : Alimentary pharmacology & therapeutics.

Harvard

Smolinska A., Bodelier A. G. L., Dallinga J. W., Masclee A. A. M., Jonkers D. M., van Schooten F. and Pierik M. J. (20170815). The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis. : Alimentary pharmacology & therapeutics.

MLA

Smolinska A, Bodelier A G L, Dallinga J W, Masclee A A M, Jonkers D M, van Schooten F-J and Pierik M J. The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis. : Alimentary pharmacology & therapeutics. 20170815.